Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-23-029126
Filing Date
2023-06-09
Accepted
2023-06-09 16:15:17
Documents
2
Group Members
EXODUSPOINT CAPITAL PARTNERS GP, LLCHYUNG LEEMICHAEL GELBAND

Document Format Files

Seq Description Document Type Size
1 SC 13G brhc20054272_sc13g.htm SC 13G 124112
2 EXHIBIT 99.1 brhc20054272_ex99-1.htm EX-99.1 9167
  Complete submission text file 0001140361-23-029126.txt   135017
Mailing Address 65 E 55TH STREET 9TH FLOOR NEW YORK NY 10022
Business Address 65 E 55TH STREET 9TH FLOOR NEW YORK NY 10022 6469409426
ExodusPoint Capital Management, LP (Filed by) CIK: 0001736225 (see all company filings)

EIN.: 371875900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Subject) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92657 | Film No.: 231005443
SIC: 2836 Biological Products, (No Diagnostic Substances)